ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,538,324 | -74.8% | 662,529 | -61.8% | 0.01% | -75.9% |
Q2 2023 | $18,007,505 | +65.5% | 1,736,500 | +29.1% | 0.05% | +58.8% |
Q1 2023 | $10,877,814 | -61.3% | 1,344,600 | -24.6% | 0.03% | -64.2% |
Q4 2022 | $28,075,950 | -3.8% | 1,782,600 | -3.8% | 0.10% | -18.8% |
Q3 2022 | $29,170,000 | +20.5% | 1,853,251 | +6.9% | 0.12% | +14.7% |
Q2 2022 | $24,205,000 | -38.3% | 1,733,900 | -23.9% | 0.10% | -34.6% |
Q1 2022 | $39,257,000 | +320.0% | 2,277,100 | +254.2% | 0.16% | +321.6% |
Q4 2021 | $9,348,000 | +32.7% | 642,900 | +64.3% | 0.04% | +19.4% |
Q3 2021 | $7,043,000 | -16.2% | 391,300 | -18.2% | 0.03% | -18.4% |
Q2 2021 | $8,404,000 | +1.7% | 478,600 | +46.0% | 0.04% | -2.6% |
Q1 2021 | $8,261,000 | +53.3% | 327,800 | +21.4% | 0.04% | +77.3% |
Q2 2018 | $5,390,000 | -57.9% | 269,922 | -63.0% | 0.02% | -58.5% |
Q1 2018 | $12,796,000 | -34.5% | 730,374 | -7.8% | 0.05% | -36.9% |
Q4 2017 | $19,531,000 | -15.2% | 792,000 | -11.2% | 0.08% | -18.4% |
Q3 2017 | $23,030,000 | -1.5% | 892,298 | +3.5% | 0.10% | -21.4% |
Q2 2017 | $23,388,000 | +70.5% | 862,402 | +87.5% | 0.13% | +72.4% |
Q1 2017 | $13,715,000 | – | 459,916 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |